Digital Pathology Blog

Blog.jpg

Posted by Keith Kaplan, MD, Chief Medical Officer 02/27/2018

Will Misters Bezos, Buffett and Dimon Fix Healthcare?

Late last month, the CEOs of Amazon, Buffett and JPMorgan Chase announced they were teaming up to form an independent healthcare company for their employees.

The details were scant and vague but mentioned the new corporation would be “free from profit-making incentives and constraints”. Mr. Buffett is quoted as saying, “The ballooning costs of health care act as a hungry tapeworm on the American economy… Our group does not come to this problem with answers. But we also do not accept it as inevitable.”

Probably not the best analogy considering tapeworms are easily treated with oral generic medications that are very low cost.

Topics: Healthcare, Studies/Reports, News

Posted by Keith Kaplan, MD, Chief Medical Officer 01/10/2017

What Does New Leadership in 2017 Mean for Pathology and Laboratory Medicine?


Regardless of your politics or mine, on January 20th a new administration will assume leadership of our country. A few months ago, if you told me I would be hearing “The Cubs won the World Series” and “Donald J. Trump will be our next President,” I would have thought the likelihood of either or both happening would be unlikely. It has been quite seachange of events since November. Although too early to think about the next election process, I am predicting the Cubs to win the World Series in 2017.

Topics: News

Posted by Elizabeth Wingard 06/05/2014

Corista Receives Frost & Sullivan’s Product Innovation Award

According to the College of American Pathologists (CAP) 2013 data, approximately 80 percent of the world’s pathologists are based in the United States. This concentration causes an increased need to access, share, and diagnose images remotely.

Topics: Digital Pathology, Studies/Reports, News

Posted by Elizabeth Wingard 05/13/2014

Pathology Perspective on New HPV Test for Cervical Cancer

There are a lot of stories being written about the human papilloma virus (HPV) test that has been approved by the FDA as a primary screening tool for cervical cancer. We decided to check in with one of the leading cytopathologists in the U.S., Dr. David Wilbur, Director of Pathology Imaging (and former Director of Cytopathology), at Massachusetts General Hospital to get his perspective.

Topics: News

Posted by Elizabeth Wingard 05/06/2014

Digital Pathology System Goes Live in UK – One of First in Europe

It’s interesting to look beyond the U.S. to see how global digital pathology adoption is progressing. After a three month test pilot last year (with more testing over the next ten months), University Hospitals Coventry and Warwickshire NHS Trust has launched a digital pathology system across its facility with the Omnyx Integrated Digital pathology system from GE Healthcare.

Topics: Digital Pathology, News